期刊文献+

Superior mesenteric venous thrombosis: Endovascular management and outcomes

下载PDF
导出
摘要 BACKGROUND Superior mesenteric venous thrombosis(SMVT)is a rare but fatal condition that is typically treated initially with anticoagulation therapy,and if this fails,with endovascular interventions.However,due to its rarity,there are not many studies that have explored the effectiveness of anticoagulation and endovascular therapies in treating SMVT.AIM To evaluate patients diagnosed with SMVT who received endovascular therapy in addition to anticoagulation and report technical and clinical outcomes.METHODS A retrospective analysis of the patients who underwent endovascular treatment for SMVT at Mayo Clinic from 2000-2019 was performed.Technical success was defined as angiographic improvement in SMV flow after intervention.Primary patency was defined as the interval from reestablishing mesenteric venous flow until the first repeat thrombotic event or need for additional intervention.Secondary patency was defined as successful restoration of flow after repeat intervention until rethrombosis or last follow-up.The adverse events were reported through Clavien-Dindo classification.RESULTS Twenty-four patients were included for analysis.The median age at intervention was 60 years(35-74 years)and 16(67%)were men.Nineteen patients presented with acute thrombosis(79.2%)and 5 with chronic thrombosis with acute manifestations(20.8%).The most commonly used endovascular modalities were thrombectomy in 12 patients(50.0%)and catheter-directed thrombolysis in 10 patients(41.7%).Technical success was achieved in 18 patients(75%).The 14-d and 30-d primary patency rates were 88.9%and 83.3%,respectively.Adverse events were reported in two patients(8.3%),one marked as grade IIIB,and 1 death marked as grade V.Five-year overall survival rate was 82%(58%-100%).CONCLUSION Endovascular intervention with anticoagulation appears to be effective for managing SMVT.This treatment combination may be considered as first-line therapy for SMVT management in select patients.
出处 《World Journal of Clinical Cases》 SCIE 2022年第1期217-226,共10页 世界临床病例杂志
  • 相关文献

参考文献1

二级参考文献13

  • 1Hyung-Kee Kim,Jae Min Chun,Seung Huh.Anticoagulation and delayed bowel resection in the management of mesenteric venous thrombosis[J].World Journal of Gastroenterology,2013,19(30):5025-5028. 被引量:15
  • 2Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:436
  • 3Amara Okoli.Additional Information on Mesenteric Venous Thrombosis[J].Mayo Clinic Proceedings.2013
  • 4Ashwani K. Singal,Patrick S. Kamath,Ayalew Tefferi.Mesenteric Venous Thrombosis[J].Mayo Clinic Proceedings.2013(3)
  • 5Stephen E. Congly,Samuel S. Lee.Portal Vein Thrombosis: Should Anticoagulation Be Used?[J].Current Gastroenterology Reports.2013(2)
  • 6John Chovanes,Jeremy W. Cannon,Timothy C. Nunez.The Evolution of Damage Control Surgery[J].Surgical Clinics of North America.2012(4)
  • 7David Bergqvist,Peter J. Svensson.Treatment of Mesenteric Vein Thrombosis[J].Seminars in Vascular Surgery.2010(1)
  • 8Alice Cenedese,Olivier Monneuse,Laurent Gruner,Etienne Tissot,Nicolas Mennesson,Xavier Barth.Initial Management of Extensive Mesenteric Venous Thrombosis: Retrospective Study of Nine Cases[J].World Journal of Surgery.2009(10)
  • 9S. Abu-Daff,N. Abu-Daff,M. Al-Shahed.Mesenteric Venous Thrombosis and Factors Associated with Mortality: A Statistical Analysis with Five-Year Follow-Up[J].Journal of Gastrointestinal Surgery.2009(7)
  • 10S.Acosta,A.Alhadad,P.Svensson,O.Ekberg.Epidemiology, risk and prognostic factors in mesenteric venous thrombosis[J].Br J Surg.2008(10)

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部